Publication:
Management of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomes

1

Issued Date

2021-03-01

Resource Type

Note

ISSN

26172216

DOI

10.21037/pcm-2020-mnsclc-09

Other identifier(s)

2-s2.0-85110627470

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Precision Cancer Medicine. Vol.4, No.March (2021)

Suggested Citation

Naiyarat Prasongsook, Thanyanan Reungwetwattana Management of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomes. Precision Cancer Medicine. Vol.4, No.March (2021). doi:10.21037/pcm-2020-mnsclc-09 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76252

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Management of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomes

Author(s)

Naiyarat Prasongsook
 Thanyanan Reungwetwattana

Other Contributor(s)

Ramathibodi Hospital
 Phramongkutklao College of Medicine

Keyword(s)

Biochemistry, Genetics and Molecular Biology
 Medicine
 Nursing

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/76252

Collections

Scopus 2021